Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA217191
Max Phase: Preclinical
Molecular Formula: C13H11N3O3S
Molecular Weight: 289.32
Molecule Type: Small molecule
Associated Items:
ID: ALA217191
Max Phase: Preclinical
Molecular Formula: C13H11N3O3S
Molecular Weight: 289.32
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(/C=C/Sc1nc(O)cc(-c2ccccc2)n1)NO
Standard InChI: InChI=1S/C13H11N3O3S/c17-11(16-19)6-7-20-13-14-10(8-12(18)15-13)9-4-2-1-3-5-9/h1-8,19H,(H,16,17)(H,14,15,18)/b7-6+
Standard InChI Key: TWLUULROUSJAIP-VOTSOKGWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 289.32 | Molecular Weight (Monoisotopic): 289.0521 | AlogP: 1.96 | #Rotatable Bonds: 4 |
Polar Surface Area: 95.34 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.46 | CX Basic pKa: 1.87 | CX LogP: 2.41 | CX LogD: 2.41 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.26 | Np Likeness Score: -0.75 |
1. Mai A, Massa S, Rotili D, Simeoni S, Ragno R, Botta G, Nebbioso A, Miceli M, Altucci L, Brosch G.. (2006) Synthesis and biological properties of novel, uracil-containing histone deacetylase inhibitors., 49 (20): [PMID:17004718] [10.1021/jm0605536] |
Source(1):